| Raul Niduaza Calvo Jr, MD | |
|
1665 Antilley Rd Ste 200, Abilene, TX 79606 | |
| (325) 437-8615 | |
| (325) 437-8697 |
| Full Name | Raul Niduaza Calvo Jr |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1665 Antilley Rd Ste 200, Abilene, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073501904 | NPI | - | NPPES |
| 114021202 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E6743 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raul Niduaza Calvo Jr, MD Po Box 5409, Abilene, TX 79608-5409 Ph: (325) 437-8615 | Raul Niduaza Calvo Jr, MD 1665 Antilley Rd Ste 200, Abilene, TX 79606 Ph: (325) 437-8615 |
News Archive
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
ARIAD Pharmaceuticals, Inc. today announced that the scientific journal, Cancer Cell, has published a comprehensive paper describing the design and preclinical characterization of AP24534, ARIAD's investigational, multi-targeted kinase inhibitor.
Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
› Verified 9 days ago
Dr. Thomas James Wray, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 23 Hospital Dr, Ste 102, Abilene, TX 79606 Phone: 325-695-6370 Fax: 325-692-6595 | |
Dr. Richard Anthony Chengson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2501 Maple St, Abilene, TX 79602 Phone: 325-795-3412 | |
Dr. David W Longley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6417 Central Park Blvd, Abilene, TX 79606 Phone: 325-695-6370 Fax: 325-692-6595 | |
Tommie Farrell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-670-7690 | |
Leisa Thornhill, RN,BSN,MSN,FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1857 Pine St Ste 100, Abilene, TX 79601 Phone: 325-672-5601 Fax: 325-672-1333 | |
Dr. Barry Lynn Moak, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1101 N 19th St, Ste 116, Abilene, TX 79601 Phone: 325-670-3920 Fax: 325-670-3929 |